UOC
DAWN

UBS O'Connor’s Day One Biopharmaceuticals DAWN Stock Holding History

UBS O'Connor’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-107,249
Closed -$697K – 328
2025
Q2 		$697K Sell
107,249
-6,001
-5% -$41.3K 0.02% 252
2025
Q1 		$898K Buy
113,250
+63,230
+126% +$681K 0.02% 194
2024
Q4 		$634K Buy
+50,020
New +$696K 0.02% 263
2023
Q2 		– Sell
-28,053
Closed -$375K – 598
2023
Q1 		$375K Buy
+28,053
New +$548K 0.01% 484
2022
Q4 		– Sell
-37,000
Closed -$741K – 84
2022
Q3 		$741K Buy
+37,000
New +$787K 0.01% 775

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return